Could sound waves boost brain health in Alzheimer's?
NCT ID NCT07143734
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tests a non-invasive device that sends low-energy pulses to the brain, aiming to improve thinking and behavior in people with early Alzheimer's. Forty adults aged 60-90 will receive either real or sham (fake) pulses over several weeks. Researchers will measure changes in memory, mood, and daily function to see if the treatment is safe and helpful.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- transcranial pulse stimulation (TPS) device
- What this could lead to
- If it works, this could point toward a non-invasive, drug-free way to slow cognitive decline and reduce neuropsychiatric symptoms in early Alzheimer's disease.
- What could go wrong
- This is a very small pilot study (40 people) testing a new device approach. The effect may be small or no better than placebo, and long-term benefits or risks are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DEMENTIA (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese UNiversity of Hong Kong
RECRUITINGHong Kong, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could tiny doses of radiation slow Alzheimer's? a new trial investigates
- Could a simple score predict dementia in depressed seniors?
- Could a diabetes drug and immune therapy slow Alzheimer's? new trial launches
- Could flickering lights and sounds slow Alzheimer's? new trial launches
- New Alzheimer's drug trial uses eye scans to track brain changes
- Scientists hunt for genes behind Early-Onset memory loss